Saridakis Iakovos, Kaiser Daniel, Maulide Nuno
Institute of Organic Chemistry, University of Vienna, Währinger Strasse 38, 1090 Vienna, Austria.
Research Platform for Next Generation Macrocycles, Währinger Strasse 38, 1090 Vienna, Austria.
ACS Cent Sci. 2020 Nov 25;6(11):1869-1889. doi: 10.1021/acscentsci.0c00599. Epub 2020 Sep 21.
Over the past several decades, macrocyclic compounds have emerged as increasingly significant therapeutic candidates in drug discovery. Their pharmacological activity hinges on their rotationally restricted three-dimensional orientation, resulting in a unique conformational preorganization and a high enthalpic gain as a consequence of high-affinity macrocycle-protein binding interactions. Synthetic access to macrocyclic drug candidates is therefore crucial. From a synthetic point of view, the efficiency of macrocyclization events commonly suffers from entropic penalties as well as undesired intermolecular couplings (oligomerization). Although over the past several decades ring-closing metathesis, macrolactonization, or macrolactamization have become strategies of choice, the toolbox of organic synthesis provides a great number of versatile transformations beyond the aforementioned. This Outlook focuses on a selection of examples employing what we term toward the synthesis of natural products or analogues.
在过去几十年中,大环化合物已成为药物研发中越来越重要的治疗候选物。它们的药理活性取决于其旋转受限的三维取向,这导致独特的构象预组织以及由于高亲和力大环-蛋白质结合相互作用而产生的高焓增益。因此,合成大环药物候选物至关重要。从合成的角度来看,大环化反应的效率通常受到熵罚以及不期望的分子间偶联(低聚)的影响。尽管在过去几十年中,关环复分解、大环内酯化或大环酰胺化已成为首选策略,但有机合成工具箱提供了许多上述方法之外的通用转化方法。本展望重点介绍了一系列采用我们称之为 “ ” 的示例,用于天然产物或类似物的合成。 (注:原文中toward the synthesis of natural products or analogues前面的内容缺失,翻译时保留了原文的不完整性)